Products & Pipeline 

Armstrong currently markets Primatene® Mist (Epinephrine Inhalation Aerosol Bronchodilator) and generic Albuterol CFC Metered Dose Inhaler. These products are generally available in most major food, drug and mass merchandise retailers across the U.S. (Albuterol requires a prescription.) 

Armstrong is also seeking FDA approval for Albuterol Sulfate MDI containing propellant hydrofluoroalkane (HFA). Armstrong has worked closely with the FDA to design studies and enroll appropriate categories of participants and expects to complete the clinical trial work required by the FDA by the end of year 2008.

Armstrong expects to utilize its research and development capabilities, both internally and through strategic alliances, to develop additional products utilizing its proprietary delivery systems. Armstrong’s Clinical Department performs clinical research to demonstrate the safety, performance, efficacy, and bioequivalence of its products.

Armstrong’s pipeline will continue to build upon its substantial experience in the development, manufacture and marketing (mainly in the U.S.) of inhaled respiratory drugs, primarily for bronchial asthma and chronic obstructive pulmonary disease (COPD), delivered by metered-dose inhalers. At the core of Armstrong’s efforts to grow its respiratory business is a continued investment in manufacturing capacity both for metered-dose inhalers and nasal sprays, which allow Armstrong to play an important role in all major markets where it operates.

Click Here for:

Primatene® Mist is the fastest type of Asthma relief available without a prescription, and is the #1 Over-The-Counter (OTC) medicine sold for the relief of physician-diagnosed Bronchial Asthma.